Efficacy of Interleukin‐12/23 and Interleukin‐23 Inhibitors for Moderately to Severely Active Crohn's Disease in Advanced Treatment Failure Populations: Systematic Review and Network Meta‐Analysis
Christopher Ma, Marla C. Dubinsky, Gil Melmed, Namita Joshi et autres